Search

Weiya Xia

from Sugar Land, TX
Age ~72
Get Report
Also known as:
Xia Weiya
Phone and address:
4614 Lake Knoll Ct, Sugar Land, TX 77479
Related to:
Lingling Zhang, 44Josh J Zhang, 38
Connected to:
Adam S Xia, 60Haiji Xia, 61Jeff Xia, 61Junwei Xia, 37Kim H Xia, 80Mingzhu Xia, 44Tian Xia, 48Yanbing Xia, 38Yanli Xia, 50Yubing Xia, 40

Weiya Xia Phones & Addresses

  • 4614 Lake Knoll Ct, Sugar Land, TX 77479
  • Missouri City, TX
  • 3838 Turnberry Cir, Houston, TX 77025
  • 5606 Bissonnet St, Houston, TX 77081 (713) 667-6921
  • Stafford, TX

Work

Company: Md anderson cancer center Jul 2018 Position: Assistant professor

Industries

Hospital & Health Care

Resumes

Resumes

Weiya Xia Photo 1

Assistant Professor

View page
Location:
Sugar Land, TX
Industry:
Hospital & Health Care
Work:
Md Anderson Cancer Center
Assistant Professor

Publications

Us Patents

Beta-Catenin Is A Strong And Independent Prognostic Factor For Cancer

View page
US Patent:
20030064384, Apr 3, 2003
Filed:
Apr 2, 2002
Appl. No.:
10/114087
Inventors:
Mien-Chie Hung - Houston TX, US
Weiya Xia - Missouri City TX, US
International Classification:
C12Q001/68
G01N033/574
US Classification:
435/006000, 435/007230
Abstract:
Cyclin D1 is one of the targets of -catenin in breast cancer cells. Transactivation of -catenin correlated significantly with cyclin D1 expression both in eight breast cell lines in vitro and in 123 patient samples. More importantly, high -catenin activity significantly correlated with poor prognosis of the patients and is a strong and independent prognostic factor in breast cancer (p

Predicting Survival Of Patients With Squamous Cell Carcinoma

View page
US Patent:
6852483, Feb 8, 2005
Filed:
Aug 11, 2000
Appl. No.:
09/637190
Inventors:
Mien-chie Hung - Houston TX, US
Weiya Xia - Missouri City TX, US
Yiu-Keung Lau - Houston TX, US
Assignee:
Kuo Kwang Biotech Corporation - Taichung
International Classification:
G01N033/50
G01N033/53
C12Q001/68
US Classification:
435 4, 435 6, 435 71, 435 72, 435 723, 436 64
Abstract:
The invention relates to methods of determining a relative probability of survival for a subject with squamous cell carcinoma by obtaining a biological sample from a subject with squamous cell carcinoma; detecting a level of maspin gene expression in the biological sample; and comparing the level with a threshold level of maspin gene expression. A level of maspin gene expression in the biological sample above the threshold level indicates a relatively high probability of survival, or a level of maspin gene expression in the biological sample below the threshold level indicates a relatively low probability of survival.
Control profile
Weiya Xia from Sugar Land, TX, age ~72 Get Report